REPLReplimune Group, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $8.41 (+0.95% today)

Market Cap: $694.44M

P/E (TTM): -2.50

Analyst Upside: 66.5%

Relative Strength (RS%): 81

-36.5% from 52-week high

Back to Scanner

REPL

NASDAQRS 81Score 47

Replimune Group, Inc.

HealthcareBiotechnology$694.44M2 setups passing
$8.41
+1.0% ($0.08)
-36.5% from 52W High
P/E (TTM)
-2.50
Fwd P/E
PEG
Analyst Upside
+66.5%
EPS Growth
Gross Margin
0.0%
ROE
-102.7%
D/E
0.37
Div Yield
0.0%
Avg Volume
3.2M

Price Chart

Key Levels

SMA 200
$7.60
SMA 50
$7.58
Price
$8.41
52W High
$13.24
Target
$14.00

Setup Radar

2/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst